Iomeron (Iomeprol)

Iomeron, an iodinated contrast agent, is employed in radiographic procedures that require enhanced visualization of vascular and tissue structures.

• Angiography: improves delineation of arterial and venous anatomy for diagnostic and interventional procedures.
• Computed tomography (CT) imaging: increases tissue contrast, aiding detection of lesions and organ assessment.
• Myelography: provides clear outlining of the spinal canal and nerve roots.
• Cerebral angiography: highlights cerebral vessels to evaluate aneurysms, stenosis, and vascular malformations.
• Vascular imaging: facilitates assessment of peripheral vessels and perfusion studies.

• Iomeprol contains a high concentration of iodine atoms that absorb X‑ray photons, raising the radiodensity of blood and extracellular fluids. When administered intravenously, intra‑arterially, or intrathecally, the iodine‑rich solution distributes within the vascular or cerebrospinal compartments, creating a contrast between enhanced structures and surrounding tissues on radiographic images. The increased attenuation results in brighter (hyperdense) regions on the image, allowing clinicians to differentiate vessels, organs, and pathological lesions with greater accuracy.

Iomeprol may be associated with a range of adverse reactions, ranging from mild to severe.

Common Side Effects

• Warm sensation or flushing
• Nausea or vomiting
• Metallic taste in the mouth
• Headache
• Dizziness
• Mild itching or rash

Serious or Rare Side Effects

• Anaphylactoid or severe allergic reactions, including bronchospasm
• Contrast‑induced nephropathy leading to acute kidney injury
• Severe hypotension or cardiovascular collapse
• Cardiac arrhythmias
• Pulmonary edema
• Neurological events such as seizures

Prior to using Iomeron, clinicians should evaluate patient risk factors and follow specific safety measures.

• Assess renal function: check serum creatinine or eGFR before administration.
• Screen for iodine or contrast media allergy: obtain detailed allergy history.
• Use the lowest effective dose: tailor volume to the imaging study.
• Monitor thyroid function in patients with thyroid disorders.
• Avoid use in pregnant women unless essential: consider fetal risk.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Iomeron can interact with certain medications and diagnostic agents, influencing safety or efficacy.

Major Interactions (Avoid)

• Metformin in patients with impaired renal function: risk of lactic acidosis.
• Radioactive iodine therapy: iodine load may interfere with treatment.
• High‑dose iodinated drugs (e.g., amiodarone): cumulative iodine may affect thyroid.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: may increase risk of contrast‑induced nephropathy.
• Diuretics and NSAIDs: can exacerbate renal impairment.
• Thyroid hormone replacement: monitor thyroid function tests after contrast exposure.